Page last updated: 2024-11-01

nylidrin and Cognition Disorders

nylidrin has been researched along with Cognition Disorders in 1 studies

Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.

Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.

Research Excerpts

ExcerptRelevanceReference
" In a dosage of 24 mg daily, it reached its peak effectiveness after 3 months of use."2.65Efficacy of nylidrin hydrochloride in the treatment of cognitive impairment in the elderly. ( Baron, JJ; Barron, PB; Bjork, AE; Garetz, FK, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garetz, FK1
Baron, JJ1
Barron, PB1
Bjork, AE1

Trials

1 trial available for nylidrin and Cognition Disorders

ArticleYear
Efficacy of nylidrin hydrochloride in the treatment of cognitive impairment in the elderly.
    Journal of the American Geriatrics Society, 1979, Volume: 27, Issue:5

    Topics: Aged; Clinical Trials as Topic; Cognition; Cognition Disorders; Double-Blind Method; Female; Humans;

1979